Effect of murine double‐minute 2 inhibitors in preclinical models of advanced clear cell carcinomas originating from ovaries and kidneys

Advanced clear cell carcinomas originating from both ovaries and kidneys with cancerous peritonitis have poor prognoses. Murine double‐minute 2 (MDM2) is a potential therapeutic target for clear cell ovarian carcinomas with WT TP53. Herein, we characterized the antiangiogenic and antitumor effects o...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cancer Sci
Prif Awduron: Kawata, Yoshiko, Nagasaka, Kazunori, Oda, Katsutoshi, Makii, Chinami, Takeuchi, Makoto, Oki, Shinya, Honjo, Harunori, Kojima, Machiko, Miyagawa, Yuko, Taguchi, Ayumi, Tanikawa, Michihiro, Sone, Kenbun, Hiraike, Haruko, Matsumoto, Yoko, Wada‐Hiraike, Osamu, Ayabe, Takuya, Osuga, Yutaka, Fujii, Tomoyuki
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2020
Pynciau:
Drug Discovery and Delivery
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7541011/
https://ncbi.nlm.nih.gov/pubmed/32713096
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14583
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg